Formulation, Characterization and Pharmacokinetics of Long-acting Ceftiofur Hydrochloride Suspension

Author(s): Shuyu Xie*, Xiaoqiu Zhang, Wanhe Luo, Kuiyu Meng, Dongmei Chen, Yuanhu Pan, Yanfei Tao, Lingli Huang, Zhenli Liu, Yulian Wang*, Zonghui Yuan*

Journal Name: Current Drug Delivery

Volume 18 , Issue 2 , 2021


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Objective: A ceftiofur hydrochloride long-acting oily suspension with no irritation was prepared by testing and optimizing the types and amounts of organic solvents, suspending agents, and surfactants.

Methods: Its properties, stability, injection site irritation, in vitro release, and pharmacokinetics in pigs were evaluated. The optimum formulation was used ethyl oleate, aluminum monosterate, and span-80 as organic solvents, suspending agents, and surfactant, respectively. The drug microparticles were uniform long strip with size of 1.53 ± 0.11 μm and no agglomerations, and were evenly dispersed. The re-dispersed time, sedimentation rate and pH value of the suspension were 4 s under a magnetic shaker rotating at 20 r/min, 1 and 5.0, respectively. It could go through 7-gage needle smoothly with withdrawal volume of 9.9 mL/min.

Results: The suspension showed good stability when stored away from light, no irritation at the injection site and sustained release in PBS buffer. After intramuscular administration, the drug concentration above 0.15 μg/mL was last for 120 h. Its elimination half-life (T1/2ke), mean residence time (MRT), and bioavailability were increased by 1.73, 1.62, and 2.16 times compared to Excenel®.

Conclusion: The results suggested that the suspension had excellent sustained-release and will make ceftiofur hydrochloride more effective and convenient to use.

Keywords: Ceftiofur hydrochloride, oily suspension, characterization, long-acting, pharmacokinetics, mean residence time (MRT).

[1]
De Jong, A.; Thomas, V.; Simjee, S.; Moyaert, H.; El Garch, F.; Maher, K.; Morrissey, I.; Butty, P.; Klein, U.; Marion, H.; Rigaut, D.; Vallé, M. Antimicrobial susceptibility monitoring of respiratory tract pathogens isolated from diseased cattle and pigs across Europe: The VetPath study. Vet. Microbiol., 2014, 172(1-2), 202-215.
[http://dx.doi.org/10.1016/j.vetmic.2014.04.008] [PMID: 24837878]
[2]
The upjohn company. Excenel® sterile suspension (ceftiofur hydrochloride) freedom information summary. NADA140-890, 1996, 1-27.
[3]
Hornish, R.E.; Kotarski, S.F. Cephalosporins in veterinary medicine - ceftiofur use in food animals. Curr. Top. Med. Chem., 2002, 2(7), 717-731.
[http://dx.doi.org/10.2174/1568026023393679] [PMID: 12052187]
[4]
Gwynne-Jones, D.; Lyall, P.; Hung, N.A.; Meikle, G. Accidental human injection of excenel RTU: Ceftiofur hydrochloride in cottonseed oil. Clin. Toxicol. (Phila.), 2008, 46(9), 908-910.
[http://dx.doi.org/10.1080/15563650801955278] [PMID: 18608258]
[5]
Fernández-Varón, E.; Cárceles-García, C.; Serrano-Rodríguez, J.M.; Cárceles-Rodríguez, C.M. Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of ceftiofur after a single intravenous, subcutaneous and subcutaneous-LA administration in lactating goats. BMC Vet. Res., 2016, 12(1), 232.
[http://dx.doi.org/10.1186/s12917-016-0863-9] [PMID: 27737655]
[6]
Slingsby, L.S.; Murison, P.J.; Goossens, L.; Engelen, M.; Waterman-Pearson, A.E. A comparison between pre-operative carprofen and a long-acting sufentanil formulation for analgesia after ovariohysterectomy in dogs. Vet. Anaesth. Analg., 2006, 33(5), 313-327.
[http://dx.doi.org/10.1111/j.1467-2995.2005.00267.x] [PMID: 16916354]
[7]
Vogelman, B.; Craig, W.A. Kinetics of antimicrobial activity. J. Pediatr., 1986, 108(5 Pt 2), 835-840.
[http://dx.doi.org/10.1016/S0022-3476(86)80754-5] [PMID: 3701535]
[8]
Helbling, I.M.; Busatto, C.A.; Karp, F.; Islan, G.A.; Estenoz, D.A.; Luna, J.A. An analysis of the microencapsulation of ceftiofur in chitosan particles using the spray drying technology. Carbohydr. Polym., 2020, 234, 115922.
[http://dx.doi.org/10.1016/j.carbpol.2020.115922] [PMID: 32070540]
[9]
Vilos, C.; Velasquez, L.A.; Rodas, P.I.; Zepeda, K.; Bong, S.J.; Herrera, N.; Cantin, M.; Simon, F.; Constandil, L. Constandil Preclinical development and in vivo efficacy of ceftiofur-PLGA microparticles. PLoS One, 2015, 10(4), e0123335.
[http://dx.doi.org/10.1371/journal.pone.0123335] [PMID: 25915043]
[10]
Lee, J.C.; Putnam, M. Veterinary sustained release parent products.Sustained-Release Inject. Prod; Senior, J.; Radomsky, M., Eds.; CRC Press, Taylor and Francis Group, 2000, pp. 328-330.
[11]
Murdan, S; Florence, A.T. Non-aqueous solutions and suspensions as sustained-release injectable formulations.Sustained-Release Inject. Prod; Senior, J.; Radomsky, M., Eds.; CRC Press, Taylor and Francis Group, 2000, pp. 76-80.
[12]
Palur, K.; Archakam, S.C.; Lingasani, N.; Diviti, R.; Kumarachari, R.K.; Velusamye, S. RP-HPLC method for the estimation of ceftiofur hydrochloride in bulk form. J. Pharm. Res., 2013, 7(3), 246-251.
[http://dx.doi.org/10.1016/j.jopr.2013.02.027]
[13]
Li, X.; Xie, S.; Pan, Y.; Qu, W.; Tao, Y.; Chen, D.; Huang, L.; Liu, Z.; Wang, Y.; Yuan, Z. Preparation, characterization and pharmacokinetics of doxycycline hydrochloride and florfenicol polyvinylpyrroliddone microparticle entrapped with hydroxypropyl-β-cyclodextrin inclusion complexes suspension. Colloids Surf. B Biointerfaces, 2016, 141, 634-642.
[http://dx.doi.org/10.1016/j.colsurfb.2016.02.027] [PMID: 26918512]
[14]
Matsumura, H.; Iguchi, S.; Yamamoto, M. Colloid chemical researches on suspension in pharmacy. II. On aging of thixotrophy in vegetable oil-aluminum stearate system. Pharm. Bull., 1957, 5(1), 21-27.
[http://dx.doi.org/10.1248/cpb1953.5.21] [PMID: 13452754]
[15]
Matsumura, H.; Iguchi, S.; Miyamoto, S.; Yamamoto, M. Colloid chemical researches on suspensions in pharmacy. I. On thixotropy in vegetable oil-aluminum stearate system. Pharm. Bull., 1955, 3(2), 131-137.
[http://dx.doi.org/10.1248/cpb1953.3.131] [PMID: 14394816]
[16]
Craigmill, A.L.; Brown, S.A.; Wetzlich, S.E.; Gustafson, C.R.; Arndt, T.S. Pharmacokinetics of ceftiofur and metabolites after single intravenous and intramuscular administration and multiple intramuscular administrations of ceftiofur sodium to sheep. J. Vet. Pharmacol. Ther., 1997, 20(2), 139-144.
[http://dx.doi.org/10.1046/j.1365-2885.1997.00820.x] [PMID: 9131541]
[17]
Goudah, A. Pharmacokinetics of ceftiofur after single intravenous and intramuscular administration in camels (Camelus dromedarius). J. Vet. Pharmacol. Ther., 2007, 30(4), 371-374.
[http://dx.doi.org/10.1111/j.1365-2885.2007.00861.x] [PMID: 17610412]
[18]
Tang, S.; Xiao, J.; Guo, G.; He, J.; Zhao, Z.; Xiao, X. Preparation of a newly formulated long-acting ceftiofur hydrochloride suspension and evaluation of its pharmacokinetics in pigs.J. vet. Pharmacol. Ther., 2009, 33, 238-245.
[19]
El Garch, F.; de Jong, A.; Simjee, S.; Moyaert, H.; Klein, U.; Ludwig, C.; Marion, H.; Haag-Diergarten, S.; Richard-Mazet, A.; Thomas, V.; Siegwart, E. Monitoring of antimicrobial susceptibility of respiratory tract pathogens isolated from diseased cattle and pigs across Europe, 2009-2012: VetPath results. Vet. Microbiol., 2016, 194, 11-22.
[http://dx.doi.org/10.1016/j.vetmic.2016.04.009] [PMID: 27102206]
[20]
Sadar, M.J.; Hawkins, M.G.; Byrne, B.A.; Cartoceti, A.N.; Keel, K.; Drazenovich, T.L.; Tell, L.A. Pharmacokinetics of a single intramuscular injection of ceftiofur crystalline-free acid in red-tailed hawks (Buteo jamaicensis). Am. J. Vet. Res., 2015, 76(12), 1077-1084.
[http://dx.doi.org/10.2460/ajvr.76.12.1077] [PMID: 26618733]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 18
ISSUE: 2
Year: 2021
Published on: 03 September, 2020
Page: [224 - 233]
Pages: 10
DOI: 10.2174/1567201817666200903165119
Price: $65

Article Metrics

PDF: 23